BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33689275)

  • 1. Se-Methylselenocysteine (SMC) Improves Cognitive Deficits by Attenuating Synaptic and Metabolic Abnormalities in Alzheimer's Mice Model: A Proteomic Study.
    Du X; Shi Q; Zhao Y; Xie Y; Li X; Liu Q; Iqbal J; Zhang H; Liu X; Shen L
    ACS Chem Neurosci; 2021 Apr; 12(7):1112-1132. PubMed ID: 33689275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Se-Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice.
    Xie Y; Liu Q; Zheng L; Wang B; Qu X; Ni J; Zhang Y; Du X
    Mol Nutr Food Res; 2018 Jun; 62(12):e1800107. PubMed ID: 29688618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Se-methylselenocysteine ameliorates mitochondrial function by targeting both mitophagy and autophagy in the mouse model of Alzheimer's disease.
    Xie Y; Ke X; Ye Z; Li X; Chen Z; Liu J; Wu Z; Liu Q; Du X
    Food Funct; 2024 Apr; 15(8):4310-4322. PubMed ID: 38529619
    [No Abstract]   [Full Text] [Related]  

  • 4. Selenium positively affects the proteome of 3 × Tg-AD mice cortex by altering the expression of various key proteins: unveiling the mechanistic role of selenium in AD prevention.
    Iqbal J; Zhang K; Jin N; Zhao Y; Liu Q; Ni J; Shen L
    J Neurosci Res; 2018 Nov; 96(11):1798-1815. PubMed ID: 30054946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium Restores Synaptic Deficits by Modulating NMDA Receptors and Selenoprotein K in an Alzheimer's Disease Model.
    Zhang ZH; Chen C; Jia SZ; Cao XC; Liu M; Tian J; Hoffmann PR; Xu HX; Ni JZ; Song GL
    Antioxid Redox Signal; 2021 Oct; 35(11):863-884. PubMed ID: 32475153
    [No Abstract]   [Full Text] [Related]  

  • 7. Different Effects and Mechanisms of Selenium Compounds in Improving Pathology in Alzheimer's Disease.
    Zhang ZH; Peng JY; Chen YB; Wang C; Chen C; Song GL
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Sodium Selenate on Hippocampal Proteome of 3×Tg-AD Mice-Exploring the Antioxidant Dogma of Selenium against Alzheimer's Disease.
    Iqbal J; Zhang K; Jin N; Zhao Y; Liu Q; Ni J; Shen L
    ACS Chem Neurosci; 2018 Jul; 9(7):1637-1651. PubMed ID: 29641182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of cerebral cortex revealed neuroprotective mechanism of esculentoside A on Alzheimer's disease.
    He Z; Zhang H; Li X; Shen L; Li N; Cheng S; Liu Q
    Eur J Pharmacol; 2024 Feb; 964():176226. PubMed ID: 38128868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease.
    Zhang ZH; Wu QY; Chen C; Zheng R; Chen Y; Ni JZ; Song GL
    Food Funct; 2018 Jul; 9(7):3965-3973. PubMed ID: 29974078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Profiling of Cerebrum Mitochondria, Myelin Sheath, and Synaptosome Revealed Mitochondrial Damage and Synaptic Impairments in Association with 3 × Tg-AD Mice Model.
    Shen L; Yang A; Chen X; Xiao S; Liu X; Lin J; Zhao Y; Zhang K; Li C; Ke J; Zhang H; Khan NU
    Cell Mol Neurobiol; 2022 Aug; 42(6):1745-1763. PubMed ID: 33560469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Dietary Supplementation with Selenium-Enriched Yeast Improves Cognitive Impairment, Reverses Synaptic Deficits, and Mitigates Tau Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Zhang ZH; Wen L; Wu QY; Chen C; Zheng R; Liu Q; Ni JZ; Song GL
    J Agric Food Chem; 2017 Jun; 65(24):4970-4979. PubMed ID: 28578584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics Evidence of the Role of TDMQ20 in the Cholinergic System and Synaptic Transmission in a Mouse Model of Alzheimer's Disease.
    Sun F; Zhao J; Zhang H; Shi Q; Liu Y; Robert A; Liu Q; Meunier B
    ACS Chem Neurosci; 2022 Nov; 13(21):3093-3107. PubMed ID: 36221993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
    Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
    J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease.
    Chen P; Wang LX; Sui XJ; Li SM; Wang Y; Liu Q; Ni JZ
    Biol Trace Elem Res; 2019 Dec; 192(2):263-276. PubMed ID: 30790121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
    Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
    Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease.
    Ying M; Sui X; Zhang Y; Sun Q; Qu Z; Luo X; Chang RC; Ni J; Liu J; Yang X
    Mol Neurobiol; 2017 Jul; 54(5):3843-3858. PubMed ID: 27335030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.